Additionally, BC mortality varies across BC subtypes, which include luminal A and B (estrogen receptor (ER) and progesterone receptor (PR) positive), HER2-positive, basal-like, and triple-negative breast cancer (TNBC). This evidence concerns the gene PGR and triple-negative breast carcinoma.